Your browser doesn't support javascript.
loading
A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy.
Xie, Wenhui; Xiao, Shiyu; Huang, Yanrong; Sun, Xiaoying; Gao, Dai; Ji, LanLan; Li, Guangtao; Zhang, Zhuoli.
Affiliation
  • Xie W; Department of Rheumatology and Clinical Immunology, Peking University First Hospital.
  • Xiao S; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Huang Y; Department of Rheumatology and Clinical Immunology, Peking University First Hospital.
  • Sun X; Department of Rheumatology and Clinical Immunology, Peking University First Hospital.
  • Gao D; Department of Rheumatology and Clinical Immunology, Peking University First Hospital.
  • Ji L; Department of Rheumatology and Clinical Immunology, Peking University First Hospital.
  • Li G; Department of Rheumatology and Clinical Immunology, Peking University First Hospital.
  • Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital.
Rheumatology (Oxford) ; 60(5): 2495, 2021 May 14.
Article in En | MEDLINE | ID: mdl-33354714
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2021 Type: Article